Skip to main content

Table 3 Postoperative complications

From: Safety and efficacy of minimally invasive McKeown esophagectomy in 1023 consecutive esophageal cancer patients: a single-center experience

Variables

N

% (n/n)

Constituent ratio % (n/n)

Total post-operative complications

370

36.2 (370/1023)

–

Major surgical complications

Unplanned second operation

10

1.0 (10/1023)

 

 Post-operative hemorrhage

4

0.4 (4/1023)

 

 Chyle leakage

4

0.4 (4/1023)

 

 Anastomotic leak

2

0.2 (2/1023)

 

Anastomotic leakage

79

7.7 (79/1023)

 

 Type I (conservative)

18

 

22.8 (18/79)

 Type II (nonsurgical intervation)

59

 

74.7 (59/79)

 Type III (second operation)

2

 

2.5 (2/79)

Anastomotic stenosis

53

5.2 (53/1023)

 

Vocal cord palsy

90

8.8 (90/1023)

 

 Temporary (recovered in 2 weeks)

68

 

75.6 (68/90)

 Permanent

22

 

24.4 (22/90)

Chylothorax

24

2.3 (24/1023)

 

Type I (Low fat dietary)

5

 

20.8 (5/24)

Type II (total parenteralnutrition)

15

 

62.5 (15/24)

Type III (surgical intervation)

4

 

16.7 (4/24)

Major non-surgical morbidity

 Pulmonary complication

137

13.4 (137/1023)

 

  Respiratory pneumonia

94

 

68.6 (94/137)

  ARDS

18

 

13.1 (18/137)

  Pneumothorax

12

 

8.8 (12/137)

  Respiratory failure

10

 

7.3 (10/137)

  Pulmonary embolism

3

 

2.2 (3/137)

Atrial fibrillation

45

4.4 (45/1023)

 

Delayed gastric emptying

14

1.4 (14/1023)

 

30-Day mortality

3

0.3 (3/1023)

 

 Anastomotic leak

1

0.1 (1/1023)

33.3 (1/3)

 DIC

1

0.1 (1/1023)

33.3 (1/3)

 Aspiration pneumonia

1

0.1 (1/1023)

33.3 (1/3)